Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Genmab And Merck Ramp Up ADC Competition In Ovarian Cancer

Apr 04 2024

• By Andrew McConaghie

Ovarian cancer — • Source: Shutterstock

Related Content

Genmab Adds To Sector ADC Buying Spree With $1.8bn ProfoundBio Acquisition

Apr 03 2024

Daiichi In Massive $22bn Global Deal With Merck & Co For Three ADCs

Oct 20 2023

Related Companies

Genmab A/S

ProfoundBio (Suzhou) Co., Ltd.

Merck & Co., Inc.

Daiichi Sankyo Co., Ltd.

Sutro Biopharma, Inc.

Additional Topics

Commercial Clinical Trials Deals Research & Development Cancer BioPharmaceutical

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.